SCHEMBL12211013

SCHEMBL12211013

c1ccc(-c2cc(-c3cccc4ccccc34)nc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.43
▸ MEN1 O00255 6/20 0.43
▸ KMT2A Q03164 6/20 0.43
▸ ALDH1A1 P00352 5/20 0.43
▸ HPGD P15428 5/20 0.43
▸ NTSR1 P30989 1/20 0.43
▸ KDM4E B2RXH2 5/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.42
▸ ATM Q13315 2/20 0.42
▸ TUBB4A P04350 1/20 0.42
▸ TUBB P07437 1/20 0.42
▸ TUBA3C P0DPH7 1/20 0.42
▸ TUBA1B P68363 1/20 0.42
▸ TUBA4A P68366 1/20 0.42
▸ TUBB4B P68371 1/20 0.42
▸ TUBB3 Q13509 1/20 0.42
▸ TUBB2A Q13885 1/20 0.42
▸ TUBB8 Q3ZCM7 1/20 0.42
▸ TUBA3E Q6PEY2 1/20 0.42
▸ TUBA1A Q71U36 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17899166 1.00 MAPT (0.43) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL13100591 0.99 MEN1 (0.42) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL14416337 0.99 MEN1 (0.42) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL13100581 0.99 MEN1 (0.42) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL10128991 0.99 MEN1 (0.42) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL13233256 0.97 TUBB4A (0.43) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL14416359 0.96 MEN1 (0.40) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL14416368 0.96 MEN1 (0.40) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL13227526 0.96 MEN1 (0.40) MAPTMEN1KMT2AALDH1A1HPGD
SCHEMBL19654626 0.95 MAPT (0.40) MAPTMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9199966-B2 Compound for an organic photoelectric device, organic photoelectric device, and display device including the same CHEIL INDUSTRIES, INC. (KR) 2015-12-01 — — US disclosed
US-9199966-B2 Compound for an organic photoelectric device, organic photoelectric device, and display device including the same CHEIL INDUSTRIES, INC. (KR) 2015-12-01 — — US disclosed
US-20110248257-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE, AND DISPLAY DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2011-10-13 — — US disclosed
US-20110248257-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE, AND DISPLAY DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2011-10-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110248257-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE, ORGANIC PHOTOELECTRIC DEVICE, AND DISPLAY DEVICE INCLUDING THE SAME PPOX, AOX1, TYR MAPT 2368/4885MEN1 2526/4885KMT2A 1399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback